ROBERT F ZIMMERMAN

Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease SACRAMENTO, CA NPI 1619294352

General Payments — all program years on this page

$1,504.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 67
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $470.64 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $470.6419

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ViiV Healthcare Company $243.8711
Gilead Sciences, Inc. $104.375
Melinta Therapeutics, Inc. $79.801
ABBVIE INC. $42.602

By program year

Program yearAmountRecords
2018 $60.794
2019 $44.133
2020 $71.164
2021 $368.5515
2022 $330.0116
2023 $158.806
2024 $470.6419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106398729 ABBVIE INC. $25.82 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106398731 ABBVIE INC. $16.78 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112701433 ViiV Healthcare Company $6.94 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112705108 ViiV Healthcare Company $8.03 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112714142 ViiV Healthcare Company $26.55 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112717116 ViiV Healthcare Company $21.85 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112719608 ViiV Healthcare Company $4.20 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112745885 ViiV Healthcare Company $8.04 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112782470 ViiV Healthcare Company $8.79 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112791054 ViiV Healthcare Company $107.35 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112810911 ViiV Healthcare Company $31.98 11/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112820003 ViiV Healthcare Company $12.06 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112825551 ViiV Healthcare Company $8.08 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133825954 Gilead Sciences, Inc. $15.80 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133825956 Gilead Sciences, Inc. $25.96 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133825958 Gilead Sciences, Inc. $22.03 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133825960 Gilead Sciences, Inc. $21.48 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133825962 Gilead Sciences, Inc. $19.10 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140486937 Melinta Therapeutics, LLC $79.80 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.